Product Information
OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1253 per EA under NDC 72888003201. Its NADAC has been published 272 times since Jun 9, 2021.
FDA first approved this application on Oct 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888003201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214415FDA Approved
10/27/2020
TE Code
AB
On Market Since
10/27/2020
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 272 times since Jun 9, 2021, and over the history we have for it it has declined 52.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1253 per EA |
|---|---|
| All-time high | $0.2649 (Jun 16, 2021) |
| All-time low | $0.0936 (Apr 17, 2024) |
| 52-week high | $0.1336 |
| 52-week low | $0.1161 |
| Median price | $0.1459 |
| Average price | $0.1589 |
| Largest weekly change | +38.9% (May 22, 2024) |
| Weeks tracked | 272 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1253 per EA (NDC 72888003201), effective Aug 19, 2026.
How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has declined 52.7%. It has been tracked across 272 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?
Since Jun 9, 2021, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.0936 (Apr 17, 2024) to a high of $0.2649 (Jun 16, 2021), with a median of $0.1459 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYBUTYNIN CL ER 15 MG TABLET, is $0.1161 per EA — about 7% below OXYBUTYNIN CL ER 15 MG TABLET.
Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?
OXYBUTYNIN CL ER 15 MG TABLET (NDC 72888003201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.